Literature DB >> 27456832

Toxoplasma gondii Infection in Mice Impairs Long-Term Fear Memory Consolidation through Dysfunction of the Cortex and Amygdala.

Fumiaki Ihara1, Maki Nishimura1, Yoshikage Muroi2, Motamed Elsayed Mahmoud1, Naoaki Yokoyama1, Kisaburo Nagamune3, Yoshifumi Nishikawa4.   

Abstract

Chronic infection with Toxoplasma gondii becomes established in tissues of the central nervous system, where parasites may directly or indirectly modulate neuronal function. Epidemiological studies have revealed that chronic infection in humans is a risk factor for developing mental diseases. However, the mechanisms underlying parasite-induced neuronal dysfunction in the brain remain unclear. Here, we examined memory associated with conditioned fear in mice and found that T. gondii infection impairs consolidation of conditioned fear memory. To examine the brain pathology induced by T. gondii infection, we analyzed the parasite load and histopathological changes. T. gondii infects all brain areas, yet the cortex exhibits more severe tissue damage than other regions. We measured neurotransmitter levels in the cortex and amygdala because these regions are involved in fear memory expression. The levels of dopamine metabolites but not those of dopamine were increased in the cortex of infected mice compared with those in the cortex of uninfected mice. In contrast, serotonin levels were decreased in the amygdala and norepinephrine levels were decreased in the cortex and amygdala of infected mice. The levels of cortical dopamine metabolites were associated with the time spent freezing in the fear-conditioning test. These results suggest that T. gondii infection affects fear memory through dysfunction of the cortex and amygdala. Our findings provide insight into the mechanisms underlying the neurological changes seen during T. gondii infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27456832      PMCID: PMC5038065          DOI: 10.1128/IAI.00217-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice.

Authors:  J Xiao; G Kannan; L Jones-Brando; C Brannock; I N Krasnova; J L Cadet; M Pletnikov; R H Yolken
Journal:  Neuroscience       Date:  2012-01-03       Impact factor: 3.590

2.  Toxoplasma gondii infection lower anxiety as measured in the plus-maze and social interaction tests in rats A behavioral analysis.

Authors:  Luis E Gonzalez; Belen Rojnik; Franklin Urrea; Haydee Urdaneta; Pierina Petrosino; Cesare Colasante; Silvano Pino; Luis Hernandez
Journal:  Behav Brain Res       Date:  2006-12-12       Impact factor: 3.332

3.  Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis.

Authors:  Jaroslav Flegr
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

4.  MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway.

Authors:  J Xiao; Y Li; E Prandovszky; S S Karuppagounder; C C Talbot; V L Dawson; T M Dawson; R H Yolken
Journal:  Neuroscience       Date:  2014-03-18       Impact factor: 3.590

5.  Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone.

Authors:  G E Stutzmann; B S McEwen; J E LeDoux
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

Review 6.  Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective.

Authors:  Geetha Kannan; Mikhail V Pletnikov
Journal:  Schizophr Bull       Date:  2012-09-01       Impact factor: 9.306

Review 7.  The HPA axis in major depression: classical theories and new developments.

Authors:  Carmine M Pariante; Stafford L Lightman
Journal:  Trends Neurosci       Date:  2008-07-31       Impact factor: 13.837

8.  The neurotropic parasite Toxoplasma gondii increases dopamine metabolism.

Authors:  Emese Prandovszky; Elizabeth Gaskell; Heather Martin; J P Dubey; Joanne P Webster; Glenn A McConkey
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

Review 9.  Norepinephrine and dopamine as learning signals.

Authors:  Carolyn W Harley
Journal:  Neural Plast       Date:  2004       Impact factor: 3.599

10.  Toxoplasma gondii infection induces dendritic retraction in basolateral amygdala accompanied by reduced corticosterone secretion.

Authors:  Rupshi Mitra; Robert Morris Sapolsky; Ajai Vyas
Journal:  Dis Model Mech       Date:  2012-10-25       Impact factor: 5.758

View more
  21 in total

1.  Chronic Toxoplasma gondii Infection Potentiates Parkinson's Disease Course in Mice Model.

Authors:  Nima Firouzeh; Naser Ziaali; Vahid Sheibani; Amir Hossein Doustimotlagh; Ali Afgar; Maryam Zamanpour; Hossein Keshavarz; Saeideh Shojaee; Reza Shafiei; Khadijeh Esmaeilpour; Zahra Babaei
Journal:  Iran J Parasitol       Date:  2021 Oct-Dec       Impact factor: 1.012

2.  Effects of Toxoplasma gondii on Levels of Interleukin-5 in Parkinson's Patients.

Authors:  S Hasan Kadhum Al-Huchaimi; G Hameed Neamah Al-Kefaei; B Ahmed Alameedy
Journal:  Arch Razi Inst       Date:  2022-02-28

3.  Toxoplasma infection induces microglia-neuron contact and the loss of perisomatic inhibitory synapses.

Authors:  Gabriela L Carrillo; Valerie A Ballard; Taylor Glausen; Zack Boone; Joseph Teamer; Cyrus L Hinkson; Elizabeth A Wohlfert; Ira J Blader; Michael A Fox
Journal:  Glia       Date:  2020-03-11       Impact factor: 7.452

4.  Toxoplasma gondii infection and risk of attention-deficit hyperactivity disorder: a systematic review and meta-analysis.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mahmood Moosazadeh; Zahra Hosseininejad; Afsaneh Amouei; Ahmad Daryani
Journal:  Pathog Glob Health       Date:  2020-03-18       Impact factor: 2.894

5.  Downregulation of the Central Noradrenergic System by Toxoplasma gondii Infection.

Authors:  Isra Alsaady; Ellen Tedford; Mohammad Alsaad; Greg Bristow; Shivali Kohli; Matthew Murray; Matthew Reeves; M S Vijayabaskar; Steven J Clapcote; Jonathan Wastling; Glenn A McConkey
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 6.  Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Ahmad Daryani
Journal:  Metab Brain Dis       Date:  2021-09-03       Impact factor: 3.584

Review 7.  Impact of Plant-Based Foods and Nutraceuticals on Toxoplasma gondii Cysts: Nutritional Therapy as a Viable Approach for Managing Chronic Brain Toxoplasmosis.

Authors:  Sijie Tan; Wen Han Tong; Ajai Vyas
Journal:  Front Nutr       Date:  2022-02-25

8.  Toxoplasma Gondii Exposure and Neurological Disorders: An Age- and Gender-Matched Case-Control Pilot Study.

Authors:  Cosme Alvarado-Esquivel; Yazmin Del Rosario Rico-Almochantaf; Jesús Hernández-Tinoco; Gerardo Quiñones-Canales; Luis Francisco Sánchez-Anguiano; Jorge Torres-González; Björn Schott; Oliver Liesenfeld; Ildiko Rita Dunay
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-11-20

Review 9.  Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system.

Authors:  Oscar A Mendez; Anita A Koshy
Journal:  PLoS Pathog       Date:  2017-07-20       Impact factor: 6.823

Review 10.  Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection.

Authors:  Ellen Tedford; Glenn McConkey
Journal:  Pathogens       Date:  2017-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.